He can't as he is limited to one post a day on BMSN board here. There is another place he "hangsout where investors go." Do a google search to find it. He'll answer there. In fact more people should go there.
As for BMSN, Koos really has taken the wind out of this with the delay in getting HemaXellerate approved for clinical trials. It will hurt the pending trading of REGEN, imho.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.